CAPRISA

CAPRISA ("Centre for the AIDS Programme of Research in South Africa") is the name of an AIDS research center based in Durban, South Africa.

CAPRISA
PurposeAIDS research
Location
Director
Salim Abdool Karim
Websitehttp://www.caprisa.org/

History

CAPRISA was established in 2002 under the National Institutes of Health program called Comprehensive International Program of Research on AIDS (CIPRA). Five partner institutions participated in the founding: University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute of Communicable Diseases, and Columbia University in New York. UNAIDS recognizes CAPRISA with the designation of "Collaborating Centre for HIV Prevention Research."[1]

CAPRISA's mission is to promote HIV prevention and research its epidemiology.[1]

CAPRISA 004
Main article: CAPRISA 004

CAPRISA 004 is the name of a clinical trial testing a microbicide which was experimentally shown to be effective in reducing women's risk of contracting HIV.[2]

References
  1. "Founding of CAPRISA". CAPRISA. Archived from the original on 19 November 2011. Retrieved 23 January 2011.
  2. Celia W. Dugger (19 July 2010). "African Studies Give Women Hope in H.I.V. Fight". The New York Times. Retrieved 23 January 2011.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.